Research Articles | Page 26 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Is blood transfusion safe during the COVID-19 pandemic? Sep 2020 Future Science OA Aplastic Anemia, Myelodysplastic Syndromes (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH)
Understanding infectious complications in patients with lower risk myelodysplastic syndromes: a step towards improving survival Jun 2025 Haematologica Myelodysplastic Syndromes (MDS)
Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy Jun 2023 Haematologica Aplastic Anemia
To Target the Untargetable: Elucidation of Synergy of APR-246 and Azacitidine in TP53 Mutant Myelodysplastic Syndromes and Acute Myeloid Leukemia Jun 2020 Haematologica Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Significant hemolysis is not required for thrombosis in paroxysmal nocturnal hemoglobinuria. Mar 2019 Haematologica Paroxysmal Nocturnal Hemoglobinuria (PNH)
Germline and somatic genetic landscape of pediatric myelodysplastic syndromes Jun 2025 Haematologica Myelodysplastic Syndromes (MDS)
Treatment of lower-risk myelodysplastic syndromes Feb 2025 Haematologica Myelodysplastic Syndromes (MDS)
Treatment of high-risk myelodysplastic syndromes Feb 2025 Haematologica Myelodysplastic Syndromes (MDS)
Diagnosis of myelodysplastic syndromes: the classic and the novel Feb 2025 Haematologica Myelodysplastic Syndromes (MDS)
Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria Aug 2023 Haematologica Paroxysmal Nocturnal Hemoglobinuria (PNH)